Seonghoon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Seonghoon Kim has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Taewon Kim
Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
5 shared publications - Seunghee Na
Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea
4 shared publications - Dong-Woo Ryu
Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
3 shared publications - Jeong Wook Park
Department of Neurology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea
3 shared publications - Woojun Kim
Department of Neurology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications - Yun Jeong Hong
Department of Neurology, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
3 shared publications
Latest Publications
- 12 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Longitudinal Inflammatory Trajectories and Recurrent Vascular Events After Acute Ischemic Stroke
Background: Inflammation contributes to the pathophysiology of acute ischemic stroke, yet no inflammatory biomarker has been established as a standard prognostic tool. Most prior studies have relied on single baseline measurements, and the prognostic relevance of longitudinal inflammatory changes remains uncertain. We investigated whether baseline levels and longitudinal trajectories of inflammatory burden index (IBI) and hs‐CRP (high‐sensitivity C‐reactive protein) are associated with recurrent stroke and major adverse cardiovascular events (MACE). Methods: In this prospective cohort study, 374 patients with acute ischemic stroke were analyzed. IBI was calculated as hs‐CRP multiplied by the neutrophil‐to‐lymphocyte ratio. Serum hs‐CRP and leukocyte differentials were measured within 24 hours of admission and at 6 months (±3 months). Baseline hs‐CRP was dichotomized at 2 mg/L and IBI at the median baseline value (4.03 mg/L), and longitudinal trajectories were defined as persistent low, increased, decreased, or persistent high based on changes between baseline and follow‐up measurements. Results: During a median follow‐up of 30.5 months, 58 patients (15.5%) experienced recurrent stroke and 69 (18.4%) experienced MACE. Baseline IBI and hs‐CRP showed inconsistent associations with these outcomes. In contrast, persistent high IBI was associated with increased risks of recurrent stroke (hazard ratio [HR] 2.46; 95% CI, 1.26–4.78; P =0.008) and MACE (HR 2.42; 95% CI, 1.33–4.43; P =0.004) compared with persistent low IBI. Persistent high hs‐CRP was associated with MACE (HR 1.92; 95% CI, 1.08–3.41; P =0.026) but not with recurrent stroke. Conclusions: Persistent high IBI trajectories were independently associated with recurrent stroke and MACE, and persistent high hs‐CRP trajectories were associated with MACE. Longitudinal assessment of inflammatory biomarkers may provide prognostic information beyond a single baseline measurement after ischemic stroke.
- 12 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Longitudinal Inflammatory Trajectories and Recurrent Vascular Events After Acute Ischemic Stroke
Background: Inflammation contributes to the pathophysiology of acute ischemic stroke, yet no inflammatory biomarker has been established as a standard prognostic tool. Most prior studies have relied on single baseline measurements, and the prognostic relevance of longitudinal inflammatory changes remains uncertain. We investigated whether baseline levels and longitudinal trajectories of inflammatory burden index (IBI) and hs‐CRP (high‐sensitivity C‐reactive protein) are associated with recurrent stroke and major adverse cardiovascular events (MACE). Methods: In this prospective cohort study, 374 patients with acute ischemic stroke were analyzed. IBI was calculated as hs‐CRP multiplied by the neutrophil‐to‐lymphocyte ratio. Serum hs‐CRP and leukocyte differentials were measured within 24 hours of admission and at 6 months (±3 months). Baseline hs‐CRP was dichotomized at 2 mg/L and IBI at the median baseline value (4.03 mg/L), and longitudinal trajectories were defined as persistent low, increased, decreased, or persistent high based on changes between baseline and follow‐up measurements. Results: During a median follow‐up of 30.5 months, 58 patients (15.5%) experienced recurrent stroke and 69 (18.4%) experienced MACE. Baseline IBI and hs‐CRP showed inconsistent associations with these outcomes. In contrast, persistent high IBI was associated with increased risks of recurrent stroke (hazard ratio [HR] 2.46; 95% CI, 1.26–4.78; P =0.008) and MACE (HR 2.42; 95% CI, 1.33–4.43; P =0.004) compared with persistent low IBI. Persistent high hs‐CRP was associated with MACE (HR 1.92; 95% CI, 1.08–3.41; P =0.026) but not with recurrent stroke. Conclusions: Persistent high IBI trajectories were independently associated with recurrent stroke and MACE, and persistent high hs‐CRP trajectories were associated with MACE. Longitudinal assessment of inflammatory biomarkers may provide prognostic information beyond a single baseline measurement after ischemic stroke.
- Open Access
- 30 September 2026
- Published by Korean Diabetes Association in The Journal of Korean Diabetes
- Vol. 27 (3) , 119-127
Effects of Hypoglycemia on the Brain: Cerebral Energy Metabolism, Autonomic Regulation, and Electroencephalographic Changes
Hypoglycemia is a frequent complication of diabetes treatment and is usually reversible after glucose administration. However, severe or prolonged hypoglycemia can lead to seizures, coma, and irreversible neurological injury. The brain is particularly vulnerable because it relies predominantly on glucose for energy production. Sustained hypoglycemia may impair cerebral energy metabolism, disrupt ionic homeostasis, and trigger excitotoxic neuronal injury. Physiological protection against hypoglycemia depends on counterregulatory responses, including suppression of insulin secretion, stimulation of glucagon and epinephrine release, and autonomic warning symptoms. Recurrent hypoglycemia may induce hypoglycemiaassociated autonomic failure, thereby increasing the risk of severe hypoglycemia. Electroencephalography (EEG) offers a real-time measure of cortical dysfunction during hypoglycemia. Typical changes include attenuation of alpha activity and progressive theta–delta slowing, whereas severe cases may show background suppression or other abnormal patterns. Because these EEG findings are not specific to hypoglycemia and have limited independent prognostic value, EEG should be interpreted as an adjunctive physiological tool in combination with blood glucose levels, clinical course, neurological examination, and neuroimaging findings.
- 30 September 2026
- Published by Korean Diabetes Association in The Journal of Korean Diabetes
- Vol. 27 (3) , 119-127
Open AccessEffects of Hypoglycemia on the Brain: Cerebral Energy Metabolism, Autonomic Regulation, and Electroencephalographic Changes
Hypoglycemia is a frequent complication of diabetes treatment and is usually reversible after glucose administration. However, severe or prolonged hypoglycemia can lead to seizures, coma, and irreversible neurological injury. The brain is particularly vulnerable because it relies predominantly on glucose for energy production. Sustained hypoglycemia may impair cerebral energy metabolism, disrupt ionic homeostasis, and trigger excitotoxic neuronal injury. Physiological protection against hypoglycemia depends on counterregulatory responses, including suppression of insulin secretion, stimulation of glucagon and epinephrine release, and autonomic warning symptoms. Recurrent hypoglycemia may induce hypoglycemiaassociated autonomic failure, thereby increasing the risk of severe hypoglycemia. Electroencephalography (EEG) offers a real-time measure of cortical dysfunction during hypoglycemia. Typical changes include attenuation of alpha activity and progressive theta–delta slowing, whereas severe cases may show background suppression or other abnormal patterns. Because these EEG findings are not specific to hypoglycemia and have limited independent prognostic value, EEG should be interpreted as an adjunctive physiological tool in combination with blood glucose levels, clinical course, neurological examination, and neuroimaging findings.
- Open Access
- 29 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Presurgical intrinsic thalamic structural covariance network organization in drug-resistant epilepsy undergoing thalamic deep brain stimulation: an exploratory study
- 29 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPresurgical intrinsic thalamic structural covariance network organization in drug-resistant epilepsy undergoing thalamic deep brain stimulation: an exploratory study
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (3) , 303-312
A Deep Learning Approach for Classifying Rapid Eye Movement Sleep Behavior Disorder Using EEGNet
Choi YH, et al. J Clin Neurol. 2026 ;22:e31. https://doi.org/10.3988/jcn.2025.0552
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (3) , 303-312
Open AccessA Deep Learning Approach for Classifying Rapid Eye Movement Sleep Behavior Disorder Using EEGNet
Choi YH, et al. J Clin Neurol. 2026 ;22:e31. https://doi.org/10.3988/jcn.2025.0552
- Open Access
- 15 June 2025
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 24 (2) , 68-78
Dizziness and neuro-otologic findings in neurodegenerative disorders: a review
Eye movement abnormalities can provide valuable diagnostic insights across various neurodegenerative disorders. This review summarizes the characteristic oculomotor findings in different neurodegenerative conditions, focusing on cognitive disorders and parkinsonian syndromes. The neural control of eye movements involves complex networks across multiple cortical regions, including the frontal eye field, supplementary eye field, and dorsolateral prefrontal cortex, functioning in coordination with subcortical structures. In Alzheimer disease, patients exhibit impaired fixation with large saccadic intrusions, prolonged saccadic latency, and increased antisaccade errors, which correlate with cognitive decline. Frontotemporal dementia shows variant-specific patterns of oculomotor dysfunction, with behavioral variant particularly affecting antisaccade performance while maintaining the ability to self-correct errors. In parkinsonian syndromes, distinctive eye movement abnormalities aid in differential diagnosis. Idiopathic Parkinson disease typically presents with hypometric saccades and increased saccadic intrusions during fixation, which correlate with disease severity. Progressive supranuclear palsy characteristically shows early vertical saccade abnormalities and frequent macro–square-wave jerks. Multiple system atrophy demonstrates various central nystagmus patterns and perverted head-shaking nystagmus, while corticobasal degeneration presents with saccadic apraxia and asymmetric oculomotor abnormalities. While eye movement abnormalities can be nonspecific and overlap between conditions, careful evaluation of oculomotor function can provide important diagnostic clues, particularly for differentiating parkinsonian syndromes. Understanding these distinct patterns of oculomotor abnormalities provides critical insights into the underlying pathophysiology and serves as a valuable tool for differential diagnosis of neurodegenerative disorders.
- 15 June 2025
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 24 (2) , 68-78
Open AccessDizziness and neuro-otologic findings in neurodegenerative disorders: a review
Eye movement abnormalities can provide valuable diagnostic insights across various neurodegenerative disorders. This review summarizes the characteristic oculomotor findings in different neurodegenerative conditions, focusing on cognitive disorders and parkinsonian syndromes. The neural control of eye movements involves complex networks across multiple cortical regions, including the frontal eye field, supplementary eye field, and dorsolateral prefrontal cortex, functioning in coordination with subcortical structures. In Alzheimer disease, patients exhibit impaired fixation with large saccadic intrusions, prolonged saccadic latency, and increased antisaccade errors, which correlate with cognitive decline. Frontotemporal dementia shows variant-specific patterns of oculomotor dysfunction, with behavioral variant particularly affecting antisaccade performance while maintaining the ability to self-correct errors. In parkinsonian syndromes, distinctive eye movement abnormalities aid in differential diagnosis. Idiopathic Parkinson disease typically presents with hypometric saccades and increased saccadic intrusions during fixation, which correlate with disease severity. Progressive supranuclear palsy characteristically shows early vertical saccade abnormalities and frequent macro–square-wave jerks. Multiple system atrophy demonstrates various central nystagmus patterns and perverted head-shaking nystagmus, while corticobasal degeneration presents with saccadic apraxia and asymmetric oculomotor abnormalities. While eye movement abnormalities can be nonspecific and overlap between conditions, careful evaluation of oculomotor function can provide important diagnostic clues, particularly for differentiating parkinsonian syndromes. Understanding these distinct patterns of oculomotor abnormalities provides critical insights into the underlying pathophysiology and serves as a valuable tool for differential diagnosis of neurodegenerative disorders.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (5) , 415-423
Deep-Learning-Based Automated REM Sleep Detection in Patients With REM Sleep Behavior Disorder: Is It Reliable?
Jung YJ, et al. J Clin Neurol. 2025 Jul;21:e26. https://doi.org/10.3988/jcn.2025.0053
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (5) , 415-423
Open AccessDeep-Learning-Based Automated REM Sleep Detection in Patients With REM Sleep Behavior Disorder: Is It Reliable?
Jung YJ, et al. J Clin Neurol. 2025 Jul;21:e26. https://doi.org/10.3988/jcn.2025.0053
- Open Access
Eccentric Vessel Wall Enhancement and hs-CRP as Prognostic Markers in Acute Ischemic Stroke: A Prospective Cohort Study
Background and Purpose Eccentric vessel wall enhancement (EVWE) and high-sensitivity C-reactive protein (hs-CRP) are inflammatory biomarkers associated with atherosclerotic disease. We investigated their prognostic value in patients with acute ischemic stroke receiving guideline-adherent medical treatment. Methods In this prospective observational cohort study, patients with acute non-cardioembolic ischemic stroke underwent vessel wall MRI and hs-CRP testing. The primary outcome was subsequent ischemic stroke during the follow-up period. The median follow-up duration was 21 months. Kaplan-Meier survival and Cox regression analysis was used to determine the associations between EVWE, hs-CRP levels, and subsequent ischemic stroke. Results Among 191 patients, 81 (42.4%) had EVWE. EVWE positivity showed a trend towards a lower risk of subsequent ischemic stroke compared to EVWE negativity (HR 0.32, 95% CI 0.12-0.87; P=0.061). Hs-CRP levels were not significantly associated with recurrent stroke risk. The combination of EVWE positivity and low hs-CRP levels (Conclusions In patients with acute ischemic stroke receiving optimal medical therapy, EVWE positivity may paradoxically indicate a lower risk of recurrent stroke. The combination of EVWE and hs-CRP status provides prognostic information, with EVWE positivity and low hs-CRP levels associated with the most favorable outcome. These findings highlight the potential role of integrating imaging and serum inflammatory biomarkers in risk stratification and management of acute ischemic stroke patients.
Open AccessEccentric Vessel Wall Enhancement and hs-CRP as Prognostic Markers in Acute Ischemic Stroke: A Prospective Cohort Study
Background and Purpose Eccentric vessel wall enhancement (EVWE) and high-sensitivity C-reactive protein (hs-CRP) are inflammatory biomarkers associated with atherosclerotic disease. We investigated their prognostic value in patients with acute ischemic stroke receiving guideline-adherent medical treatment. Methods In this prospective observational cohort study, patients with acute non-cardioembolic ischemic stroke underwent vessel wall MRI and hs-CRP testing. The primary outcome was subsequent ischemic stroke during the follow-up period. The median follow-up duration was 21 months. Kaplan-Meier survival and Cox regression analysis was used to determine the associations between EVWE, hs-CRP levels, and subsequent ischemic stroke. Results Among 191 patients, 81 (42.4%) had EVWE. EVWE positivity showed a trend towards a lower risk of subsequent ischemic stroke compared to EVWE negativity (HR 0.32, 95% CI 0.12-0.87; P=0.061). Hs-CRP levels were not significantly associated with recurrent stroke risk. The combination of EVWE positivity and low hs-CRP levels (Conclusions In patients with acute ischemic stroke receiving optimal medical therapy, EVWE positivity may paradoxically indicate a lower risk of recurrent stroke. The combination of EVWE and hs-CRP status provides prognostic information, with EVWE positivity and low hs-CRP levels associated with the most favorable outcome. These findings highlight the potential role of integrating imaging and serum inflammatory biomarkers in risk stratification and management of acute ischemic stroke patients.
- Open Access
- 30 April 2024
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 26 (1) , 9-13
Colchicine-Induced Neuromyopathy with Myotonic Discharges in a Patient Using Concomitant Diuretics
Colchicine is a widely used anti-inflammatory medication, but its neuromuscular adverse effects are under-recognized. One month ago, a 70-year-old woman presented to our clinic for an evaluation of general weakness. She had been taking colchicine and diuretics daily. The weakness, which began in both thighs and lower legs approximately 4 weeks before her visit, had progressively worsened. The patient also experienced mild paresthesia and hypoesthesia in both arms and legs. Her serum creatine kinase and aldolase levels were elevated, and nerve conduction studies indicated a motor-dominant sensorimotor polyneuropathy of the axonal type. Needle electromyography showed prominent fibrillation potentials, positive sharp waves, and myotonic discharges. Suspecting colchicine-induced neuromyopathy, we discontinued the colchicine and diuretics, after which her symptoms resolved.
- 30 April 2024
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 26 (1) , 9-13
Open AccessColchicine-Induced Neuromyopathy with Myotonic Discharges in a Patient Using Concomitant Diuretics
Colchicine is a widely used anti-inflammatory medication, but its neuromuscular adverse effects are under-recognized. One month ago, a 70-year-old woman presented to our clinic for an evaluation of general weakness. She had been taking colchicine and diuretics daily. The weakness, which began in both thighs and lower legs approximately 4 weeks before her visit, had progressively worsened. The patient also experienced mild paresthesia and hypoesthesia in both arms and legs. Her serum creatine kinase and aldolase levels were elevated, and nerve conduction studies indicated a motor-dominant sensorimotor polyneuropathy of the axonal type. Needle electromyography showed prominent fibrillation potentials, positive sharp waves, and myotonic discharges. Suspecting colchicine-induced neuromyopathy, we discontinued the colchicine and diuretics, after which her symptoms resolved.
- Open Access
- 30 April 2024
- Published by The Korean Headache Society in Headache and Pain Research
- Vol. 25 (1) , 3-15
Migraines in Women: A Focus on Reproductive Events and Hormonal Milestones
Migraine, a prevalent neurological disorder, is more common in women than in men. This sex difference is more pronounced after menarche and diminishes after menopause. Migraines in women are influenced by the menstrual cycle, pregnancy, and lactation, suggesting a connection to sex hormones, known as the estrogen withdrawal theory. Beyond endogenous hormonal changes accompanying reproductive events, exogenous hormonal factors such as contraceptives or hormone replacement therapy may also affect migraines. The hormonal influence cannot be explained simply by serum estrogen levels; instead, it involves a complex interplay of various factors. Here, we delineate aspects of migraines associated with endogenous and exogenous hormonal changes over the course of a woman’s life, exploring the mechanisms and contributing factors through which sex hormones influence migraines.
- 30 April 2024
- Published by The Korean Headache Society in Headache and Pain Research
- Vol. 25 (1) , 3-15
Open AccessMigraines in Women: A Focus on Reproductive Events and Hormonal Milestones
Migraine, a prevalent neurological disorder, is more common in women than in men. This sex difference is more pronounced after menarche and diminishes after menopause. Migraines in women are influenced by the menstrual cycle, pregnancy, and lactation, suggesting a connection to sex hormones, known as the estrogen withdrawal theory. Beyond endogenous hormonal changes accompanying reproductive events, exogenous hormonal factors such as contraceptives or hormone replacement therapy may also affect migraines. The hormonal influence cannot be explained simply by serum estrogen levels; instead, it involves a complex interplay of various factors. Here, we delineate aspects of migraines associated with endogenous and exogenous hormonal changes over the course of a woman’s life, exploring the mechanisms and contributing factors through which sex hormones influence migraines.
- Open Access
- 31 December 2023
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 15 (2) , 114-116
Hirayama Disease with Isolated Spinal Cord Atrophy
This report presents a young-aged man with Hirayama disease who had muscle atrophy and weakness strictly confined to the C8/T1 myotome that consistently accorded with electromyographic results. In the magnetic resonance imaging (MRI) evaluation, there was only a prominent isolated spinal cord atrophy without any typical flexion MRI features of Hirayama disease. We speculate that it may be possible to have only isolated spinal cord atrophy as a limited form in Hirayama disease even in the absence of anterior displacement of the dura in the flexed position. These findings emphasize the importance of understanding both typical and atypical limited findings of the MRI imaging features of Hirayama disease, because it’s critical to distinguish Hirayama disease, mostly showing benign course, from fatal conditions like amyotrophic lateral sclerosis.
- 31 December 2023
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 15 (2) , 114-116
Open AccessHirayama Disease with Isolated Spinal Cord Atrophy
This report presents a young-aged man with Hirayama disease who had muscle atrophy and weakness strictly confined to the C8/T1 myotome that consistently accorded with electromyographic results. In the magnetic resonance imaging (MRI) evaluation, there was only a prominent isolated spinal cord atrophy without any typical flexion MRI features of Hirayama disease. We speculate that it may be possible to have only isolated spinal cord atrophy as a limited form in Hirayama disease even in the absence of anterior displacement of the dura in the flexed position. These findings emphasize the importance of understanding both typical and atypical limited findings of the MRI imaging features of Hirayama disease, because it’s critical to distinguish Hirayama disease, mostly showing benign course, from fatal conditions like amyotrophic lateral sclerosis.